Detalhe da pesquisa
1.
Central nervous system status is prognostic in T-cell acute lymphoblastic leukemia: a Children's Oncology Group report.
Blood
; 141(15): 1802-1811, 2023 04 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36603187
2.
Prognostic significance of ETP phenotype and minimal residual disease in T-ALL: a Children's Oncology Group study.
Blood
; 142(24): 2069-2078, 2023 12 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37556734
3.
Impaired neurocognitive functioning 3 months following diagnosis of high-risk acute lymphoblastic leukemia: A report from the Children's Oncology Group.
Pediatr Blood Cancer
; 70(7): e30350, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37129114
4.
Assessment of proxy-reported responses as predictors of motor and sensory peripheral neuropathy in children with B-lymphoblastic leukemia.
Pediatr Blood Cancer
; 70(11): e30634, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37592363
5.
Sex-based disparities in outcome in pediatric acute lymphoblastic leukemia: a Children's Oncology Group report.
Cancer
; 128(9): 1863-1870, 2022 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35201611
6.
Outcomes after late bone marrow and very early central nervous system relapse of childhood B-acute lymphoblastic leukemia: a report from the Children's Oncology Group phase III study AALL0433.
Haematologica
; 106(1): 46-55, 2021 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32001530
7.
Late isolated central nervous system relapse in childhood B-cell acute lymphoblastic leukemia treated with intensified systemic therapy and delayed reduced dose cranial radiation: A report from the Children's Oncology Group study AALL02P2.
Pediatr Blood Cancer
; 68(12): e29256, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34302704
8.
Prognostic impact of minimal residual disease at the end of consolidation in NCI standard-risk B-lymphoblastic leukemia: A report from the Children's Oncology Group.
Pediatr Blood Cancer
; 68(4): e28929, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33559396
9.
Toxicity associated with intensive postinduction therapy incorporating clofarabine in the very high-risk stratum of patients with newly diagnosed high-risk B-lymphoblastic leukemia: A report from the Children's Oncology Group study AALL1131.
Cancer
; 124(6): 1150-1159, 2018 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29266189
10.
Longitudinal analysis of quality-of-life outcomes in children during treatment for acute lymphoblastic leukemia: A report from the Children's Oncology Group AALL0932 trial.
Cancer
; 124(3): 571-579, 2018 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29112230
11.
KMT2A partner genes in infant acute lymphoblastic leukemia have prognostic significance and correlate with age, white blood cell count, sex, and central nervous system involvement: a Children's Oncology Group P9407 trial study.
Haematologica
; 108(10): 2865-2871, 2023 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36861410
12.
Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia.
N Engl J Med
; 371(11): 1005-15, 2014 Sep 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-25207766
13.
Prognostic significance of minimal residual disease in high risk B-ALL: a report from Children's Oncology Group study AALL0232.
Blood
; 126(8): 964-71, 2015 Aug 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-26124497
14.
Genome-wide analysis links NFATC2 with asparaginase hypersensitivity.
Blood
; 126(1): 69-75, 2015 Jul 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-25987655
15.
Outstanding outcomes in infants with KMT2A-germline acute lymphoblastic leukemia treated with chemotherapy alone: results of the Children's Oncology Group AALL0631 trial.
Haematologica
; 107(5): 1205-1208, 2022 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35172563
16.
Prospective, longitudinal assessment of quality of life in children from diagnosis to 3 months off treatment for standard risk acute lymphoblastic leukemia: Results of Children's Oncology Group study AALL0331.
Int J Cancer
; 138(2): 332-9, 2016 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26235006
17.
Prevalence and predictors of anxiety and depression after completion of chemotherapy for childhood acute lymphoblastic leukemia: A prospective longitudinal study.
Cancer
; 122(10): 1608-17, 2016 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27028090
18.
HLA-DRB1*07:01 is associated with a higher risk of asparaginase allergies.
Blood
; 124(8): 1266-76, 2014 Aug 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-24970932
19.
A Pilot Study of Intensified PEG-Asparaginase in High-risk Acute Lymphoblastic Leukemia: Children's Oncology Group Study AALL08P1.
J Pediatr Hematol Oncol
; 38(6): 409-17, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27299599
20.
Application of a standardized screening protocol for diagnosis of invasive mold infections in children with hematologic malignancies.
Support Care Cancer
; 24(12): 5025-5033, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27518197